Femilis LNG IUS

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Intrauterine

Duration Type: Long-acting

Description: IUS releasing ~20mcg of levonorgestrel daily, expected to last for at least 5 years. In vitro study suggest constant rate of LNG release similar to the Mirena. Four products with the Femilis name have been developed. They are various sizes, contain different amounts of levonorgestrel, and have different durations of use.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Post-development

Project Stage: Regulatory

Download Product Report